Aller au contenu
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Langue
Tous les champs
Titre
Auteur
Sujet
Cote
ISBN/ISSN
Tag
Rechercher
Recherche avancée
Economic analysis of simvastat...
Citer
Envoyer par SMS
Envoyer par courriel
Imprimer
Exporter les notices
Exporter vers RefWorks
Exporter vers EndNoteWeb
Exporter vers EndNote
Permalien
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
Détails bibliographiques
Auteurs principaux:
Mihaylova, B
,
Armitage, J
,
Briggs, A
,
Gray, A
,
Parish, S
,
Collins, R
,
Collaborati, H
Format:
Conference item
Publié:
2005
Exemplaires
Description
Documents similaires
Affichage MARC
Description
Résumé:
Documents similaires
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
par: Mihaylova, B, et autres
Publié: (2005)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
par: Mihaylova, B, et autres
Publié: (2006)
N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
par: Emberson, J, et autres
Publié: (2005)
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
par: Armitage, J, et autres
Publié: (2009)
N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
par: Emberson, J, et autres
Publié: (2005)